Erlotinib Supplier-Buyer Network — Trade Flow Analysis

Name: Erlotinib Supplier-Buyer Trade Network Dataset — 94+ Indian Exporters, 13+ Importers, 55+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Erlotinib supplier network, Erlotinib buyers, pharmaceutical export India, Erlotinib trade data

TransData Nexus

Erlotinib

India Pharmaceutical Trade Intelligence

$2.7M94 Suppliers55 CountriesHS 30049049

ExportsIndia → UNITED STATES21.0%India → THAILAND18.9%

ImportsITALY → India$377.7K BRAZIL → India$19.7K

#1 Supplier: NATCO PHARMA #1 Buyer: ATLANTA MEDICARE

Who Supplies Erlotinib? Top Manufacturers & Buyers 2026 — NATCO PHARMA LIMITED Leads | TransData Nexus | TransData Nexus

1CIPLA LIMITED

CIPLA LIMITED is the first-largest Erlotinib exporter from India, with a market share of 15.3% and a total export value of $409.5K across 4 shipments. Their average shipment value of $102.4K is above the market average of $8.0K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 2 named buyers in our database. 'TO THE ORDER is the dominant customer, accounting for 80.8% of this supplier's tracked business. Top customers include:

• 'TO THE ORDER — $330.7K across 3 shipments (80.8% of this supplier's total exports)

• MEDPRO PHARMACEUTICA (PTY) LTD, — $78.8K across 1 shipments (19.2% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $102.4K is 1183% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.

2MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED is the second-largest Erlotinib exporter from India, with a market share of 9.2% and a total export value of $245.3K across 32 shipments. Their average shipment value of $7.7K is below the market average of $8.0K, reflecting a high-volume, competitive pricing strategy.

MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER OF — $73.0K across 10 shipments (29.8% of this supplier's total exports)

• MSN LABS PERU SAC CAL. — $53.3K across 7 shipments (21.7% of this supplier's total exports)

• 'TO THE ORDER — $43.3K across 6 shipments (17.7% of this supplier's total exports)

• MSN LABS CHILE SPA R — $38.5K across 5 shipments (15.7% of this supplier's total exports)

• MSN LABS PERU SAC — $37.2K across 5 shipments (15.2% of this supplier's total exports)

Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (32 shipments) at a per-shipment value of $7.7K, indicating a broad distribution network with many smaller, regular orders.

3ALEMBIC PHARMACEUTICALS LIMITED

ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Erlotinib exporter from India, with a market share of 4.0% and a total export value of $106.9K across 9 shipments. Their average shipment value of $11.9K is above the market average of $8.0K, suggesting premium or bulk contract pricing.

ALEMBIC PHARMACEUTICALS LIMITED serves 1 named buyer in our database. J. KNIPPER & COMPANY is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• J. KNIPPER & COMPANY — $106.9K across 9 shipments (100.0% of this supplier's total exports)

Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $11.9K is 49% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.

4NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is the fourth-largest Erlotinib exporter from India, with a market share of 4.0% and a total export value of $106.3K across 11 shipments. Their average shipment value of $9.7K is above the market average of $8.0K, suggesting premium or bulk contract pricing.

NATCO PHARMA LIMITED serves 3 named buyers in our database. ATLANTA MEDICARE CO.LIMITED is the dominant customer, accounting for 98.5% of this supplier's tracked business. Top customers include:

• ATLANTA MEDICARE CO.LIMITED — $104.7K across 11 shipments (98.5% of this supplier's total exports)

• EVEREST BANK LTD — $1.2K across 0 shipments (1.1% of this supplier's total exports)

• EVEREST BANK LTD — $420 across 0 shipments (0.4% of this supplier's total exports)

Key Insight: NATCO PHARMA LIMITED's per-shipment value of $9.7K is 21% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.

5RELIANCE LIFE SCIENCES PRIVATE LIMITED

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Erlotinib exporter from India, with a market share of 3.8% and a total export value of $102.9K across 7 shipments. Their average shipment value of $14.7K is above the market average of $8.0K, suggesting premium or bulk contract pricing.

RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 4 named buyers in our database. PHARMIS SARL is the dominant customer, accounting for 60.7% of this supplier's tracked business. Top customers include:

• PHARMIS SARL — $62.5K across 4 shipments (60.7% of this supplier's total exports)

• TURGUT ILACLARI A.S. — $18.9K across 1 shipments (18.4% of this supplier's total exports)

• TURGUT ILACLARI A.S. — $18.4K across 1 shipments (17.9% of this supplier's total exports)

• BIOTENG S A — $3.1K across 0 shipments (3.0% of this supplier's total exports)

Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $14.7K is 84% above the market average of $8.0K, consistent with large-order contracts or value-added formulations.

6VEXXA LIFESCIENCES PVT. LTD.

VEXXA LIFESCIENCES PVT. LTD. is the fifth-largest Erlotinib exporter from India, with a market share of 3.6% and a total export value of $97.1K across 16 shipments. Their average shipment value of $6.1K is below the market average of $8.0K, reflecting a high-volume, competitive pricing strategy.

VEXXA LIFESCIENCES PVT. LTD. serves 3 named buyers in our database. VE PHARMA INC is the dominant customer, accounting for 70.3% of this supplier's tracked business. Top customers include:

• VE PHARMA INC — $68.2K across 11 shipments (70.3% of this supplier's total exports)

• VE PHARMA INC. — $19.3K across 3 shipments (19.9% of this supplier's total exports)

• VE PHARMA INC — $9.5K across 2 shipments (9.8% of this supplier's total exports)

Key Insight: VEXXA LIFESCIENCES PVT. LTD. operates with high shipment frequency (16 shipments) at a per-shipment value of $6.1K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Erlotinib imports from India, with a total trade value of $562.1K across 10 shipments — representing a 21.0% share of all Erlotinib exports. The average shipment value of $56.2K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Erlotinib importers in United States: J. KNIPPER & COMPANY is the largest buyer, accounting for 19.0% ($106.9K) of this market's total imports.

• J. KNIPPER & COMPANY — $106.9K (19.0% of United States's total)

• BRECKENRIDGE PHARMACEUTICAL, INC — $91.2K (16.2% of United States's total)

• NOVADOZ PHARMACEUTICALS LLC — $35.7K (6.4% of United States's total)

Key Insight: United States's per-shipment average of $56.2K (605% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Erlotinib imports from India.

Primary Market

Secondary Market

2Thailand

Thailand ranks as the second-largest destination for Erlotinib imports from India, with a total trade value of $506.0K across 5 shipments — representing a 18.9% share of all Erlotinib exports. The average shipment value of $101.2K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Erlotinib importers in Thailand: ATLANTA MEDICARE CO.LTD is the largest buyer, accounting for 46.6% ($235.7K) of this market's total imports.

• ATLANTA MEDICARE CO.LTD — $235.7K (46.6% of Thailand's total)

• ATLANTA MEDICARE CO.LIMITED — $104.7K (20.7% of Thailand's total)

Key Insight: Thailand's per-shipment average of $101.2K (1169% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Erlotinib imports from India.

Primary Market

Secondary Market

3Philippines

Philippines ranks as the third-largest destination for Erlotinib imports from India, with a total trade value of $331.5K across 21 shipments — representing a 12.4% share of all Erlotinib exports. The average shipment value of $15.8K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Erlotinib importers in Philippines: VE PHARMA INC. is the largest buyer, accounting for 55.9% ($185.1K) of this market's total imports.

• VE PHARMA INC. — $185.1K (55.9% of Philippines's total)

• VE PHARMA INC — $142.3K (42.9% of Philippines's total)

Key Insight: Philippines's per-shipment average of $15.8K (98% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Erlotinib imports from India.

Primary Market

Secondary Market

4Saudi Arabia

Saudi Arabia ranks as the fourth-largest destination for Erlotinib imports from India, with a total trade value of $330.7K across 0 shipments — representing a 12.3% share of all Erlotinib exports. The average shipment value of $330.7K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations.

Key Insight: Saudi Arabia's per-shipment average of $330.7K (4046% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Saudi Arabia is a key market for Erlotinib imports from India.

Primary Market

Secondary Market

5Peru

Peru ranks as the fifth-largest destination for Erlotinib imports from India, with a total trade value of $152.0K across 5 shipments — representing a 5.7% share of all Erlotinib exports. The average shipment value of $30.4K is above the global average of $8.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Erlotinib importers in Peru: MSN LABS PERU SAC CAL. is the largest buyer, accounting for 35.1% ($53.3K) of this market's total imports.

• MSN LABS PERU SAC CAL. — $53.3K (35.1% of Peru's total)

• MSN LABS PERU SAC — $37.2K (24.5% of Peru's total)

Key Insight: Peru's per-shipment average of $30.4K (281% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Peru is a key market for Erlotinib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Erlotinib.
2.Flow Mapping: 94 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 336 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 55 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

336 Verified Shipments

94 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Erlotinib

Erlotinib

Who Supplies Erlotinib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Erlotinib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Erlotinib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1CIPLA LIMITED

2MSN LABORATORIES PRIVATE LIMITED

3ALEMBIC PHARMACEUTICALS LIMITED

4NATCO PHARMA LIMITED

5RELIANCE LIFE SCIENCES PRIVATE LIMITED

6VEXXA LIFESCIENCES PVT. LTD.

From Indian Factories to Global Pharmacies — How Erlotinib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Erlotinib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Thailand

3Philippines

4Saudi Arabia

5Peru

People Also Ask — Erlotinib Supplier & Trade Network

Erlotinib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology